Open an Account  | Login | Demo
Wednesday, May 21, 2008
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity  |  Derivatives  |  IPO  |  Commodity  |  Mutual Funds  |  Offshore  |  Insurance  |  Gold coins  |  PMS  |  Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Offshore News   


Equity News
May 20 2008 6:59PM
Perk Pharmaceuticals net profit declines 50.00% in the year ended March 2008
Net profit of Perk Pharmaceuticals declined 50.00% to Rs 0.15 crore in the year ended March 2008 as against Rs 0.30 crore during the previous year ended March 2007. Sales declined 8.45% to Rs 1.30 crore in the year ended March 2008 as against Rs 1.42 crore during the year ended March 2007.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Charting
 
Customer Service
 
Contact Us
 
Site Map
 






SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in | Media Center
Copyright© 2008. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected] 110